Intermediates

S.No PRODUCT NAME CAS NO END STAGE
1 Citirizine di hydrochloride    
A P- chloro benzophenone 134-85-0 KSM-1
B P- chloro Benzhydryl chloride 134-83-8 Key intermediate
C 1-(4-Chlorobenzhydryl)piperazine 303-26-4 Key intermediate
       
2 DIBUCAINE    
A 2-Hydroxy quinolone carboxylic acid 15733-89-8 Key intermediate
B 4-Methylcarbostyril 607-66-9 Key intermediate
       
3 ATOMAXETINE    
A 3-chloro-N,N-Dimethyl-3-phenyl-1-propanamine.HCl 79130-51-1 Key intermediate
       
4 AZILSARTAN    
A Methyl 2-ethoxy-1-((2′-(N-hydroxycarbamimidoyl)-[1,1′-biphenyl]-4-yl) methyl)-1H-benzo[d]imidazole-7-carboxylate, 147403-65-4 Key intermediate
  Methyl 2-ethoxy-1-((2′-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl) methyl)-1H-benzo[d]imidazole-7-carboxylate 147403-52-9 Key intermediate
       
5 APREMALAST    
A 3-ACETAMIDOPTHALIC ANHYDRIDE 6296-53-3 Key intermediate
       
6 CINACALCET    
A R-(+)-1-(1-Napthyl) ethyl Amine 3886-70-2 Key intermediate
B R-(+)-1-(1-Napthyl) ethyl Amine Mandalate salt 1073144-62-3 Key intermediate
       
7 DHARUNAVIR    
A tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl[(4-nitrophenyl) sulfonyl] amino] propyl] carbamate 191226-98-9 Key intermediate
B 4-AMINO-N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-N-ISOBUTYLBENZENE-1-SULFONAMIDE 169280-56-2 Key intermediate
       
8 DULOXETINE    
A RS-N, N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine 13636-02-7 Key intermediate
B S (-)-N, N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamin 132335-44-5 Key intermediate
C S-(+)-N, N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate 132335-47-8 Key intermediate
       
9 DABIGATRAN    
A N-(4-cyanophenyl) glycine 42288-26-6 Key intermediate
B N((2(((4(aminoiminomethyl)phenyl) amino) methyl)-1-methyl-1H-benzimidazol-5-yl) carbonyl)-N-2-pyrimidinyl-β-alanineethyl ester hydrochloride salt 211914-50-0 Key intermediate
C 3-[3-Amino-4-(methylamino)-N-(2-pyridyl) 212322-56-0 Key intermediate
             benzamido] propionic Acid Ethyl Ester    
D 3-[[[2-[[(4-Cyanophenyl) amino] methyl]-1-methyl-1H-benzimidazol-5-yl] carbonyl] pyridin-2-ylamino] propionic acid ethyl ester 211915-84-3 Key intermediate
E Ethyl 3-(pyridin-2-ylamino) propanoate 103041-38-9 Key intermediate
F 3-Methyl-4-Amino-Benzoic acid 66315-15-9 Key intermediate
       
10 FINGOLIMOD    
A Diethyl acetamidomalonate 1068-90-2 Key intermediate
       
11 FAVIPIPRAVIR    
A 6-Bromo-3-Hydroxypyrazine-2-Carboxamide 259793-88-9 Key intermediate
B 3-hydroxy pyrazine-2-carboxamide 55321-99-8 Key intermediate
       
12 IRBESARTAN    
A 2-n-Butyl-1,3-diazaspiro [4.4] non-1-en-4-one, 2-N-BUTYL-1,3-DIAZA-SPIRO [4,4] NON-1-EN-4-ONE HYDROCHLORIDE 138402-05-8 Key intermediate
       
13 LURASIDONE    
A (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione 14805-29-9 Key intermediate
B 3-(1-Piperazinyl)-1,2-benzisothiazole 87691-87-0 Key intermediate
C (R, R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane 186204-35-3 Key intermediate
       
14 MEMANTINE HYDROCHLORIDE    
A 1-Bromo-3,5-dimethyladamantane 941-37-7 Key intermediate
B 1-Actamido-3,5-dimethyladmantane 19982-07-1 Key intermediate
       
15 MONTELUKAST    
A montelucastDicyclohexylamine salt 577953-88-9 N-1
B 2(1-(mercapto methyl)cyclo propyl)acetic acid 162515-68-6 Key intermediate
       
16 OMEPRAZOLE    
A OMEPRAZOLE SULPHIDE 73590-85-9 N-1
       
17 REMDESIVIR    
A (3aR,5R,6R,6aR)-5-((R) 2,2 dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl tetrahydrofuro(2,3-d) (1,3) dioxol-6-ol N/A Key Rawmaterial
       
18 SILODOSIN    
A 2-(2-(2,2,2-trifluoroethoxy)-phenoxy)-ethyl methanesulfonate 160969-03-9 Key intermediate
B 5-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(phenylmethoxy) propyl]-1H-indole-7-carbonitrile 459868-73-6 Key intermediate
       
19 TRAZODONE.HCl    
A Bis (2-chloroethyl) amine hydrochloride 821-48-7 Key intermediate
B 1-(3-Chlorophenyl) piperazine hydrochloride 13078-15-4 Key intermediate
       
20 VERTIOXETINE    
A 2,4-Dimethylbenzene thiol   Key intermediate
       
21 VERAPAMIL    
A Homoveratronitrile 93-17-4 Key intermediate
B 3,4-Dimethoxyphenethylamine 120-20-7 Key intermediate
C Isopropyl Veratronitrile 20850-49-1 Key intermediate
D Homo Veratric Acid 93-40-3 Key intermediate
E N-Methyl Homo veratryl amine Hydrochloride 13078-76-7 Key intermediate
       
22 VILAZODONE    
  Ethyl 5-amino-1-benzofuran-2-carboxylate 174775-48-5 Key intermediate
       
23 3,4 -Di hydroxy benzoic acid ethyl ester N/A KRM